Noradrenalin Kabi (Noradrenaline Tartrate)

Noradrenaline Tartrate, the active ingredient in Noradrenalin Kabi, is a sympathomimetic (vasopressor) presented as an injection solution for intravenous use. It is employed to raise blood pressure in acute hypotensive states such as septic shock, cardiac arrest, and postoperative vasoplegia.

GNH USA supplies Noradrenalin Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, intensive care units and transplant centres worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution.

Noradrenalin Kabi is a vasopressor used in critical care to support circulatory function during severe hypotension. - Hypotension: restores arterial pressure and improves organ perfusion in patients with acute low blood pressure. - Septic shock: counteracts vasodilatory failure, raising systemic vascular resistance to maintain hemodynamic stability. - Cardiac arrest: provides immediate pressor support during resuscitation efforts to sustain coronary and cerebral perfusion. - Post‑operative vasoplegia: reverses refractory vasodilation after major surgery, helping to achieve target blood pressure.

Administration of Noradrenalin may be associated with a range of adverse reactions, varying from mild to severe. Common Side Effects: - Headache: mild to moderate intensity. - Tachycardia: increased heart rate. - Nausea: occasional gastrointestinal discomfort. - Anxiety: feelings of restlessness. Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Severe hypertension: excessive rise in blood pressure. - Tissue necrosis: extravasation at the injection site causing local injury. - Myocardial ischemia: reduced coronary blood flow leading to chest pain.

Clinicians should observe specific precautions when using Noradrenalin to minimize risks and ensure therapeutic benefit. - Monitor blood pressure continuously: adjust infusion rate to maintain target MAP. - Assess cardiac function: avoid excessive dosing in patients with ischemic heart disease. - Use central venous access when possible: reduces risk of extravasation. - Titrate slowly in septic shock: prevent abrupt hypertension. - Avoid concurrent use with MAO inhibitors: risk of hypertensive crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Noradrenalin can interact with several agents, altering its efficacy or safety profile. Major Interactions (Avoid): - MAO inhibitors: synergistic vasoconstriction may cause severe hypertension. - Tricyclic antidepressants: additive pressor effects increase risk of hypertensive emergencies. Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt β1‑mediated cardiac stimulation, requiring dose adjustment. - Calcium channel blockers: combined vasoconstriction can exacerbate hypertension. - Diuretics: volume depletion may enhance pressor response, necessitating careful monitoring.